Dermatología Experimental y Biología Cutánea

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • López A, Charbonnier D, Vela P, Díez B, Río P, Sánchez R, Alberquilla O, Martín-Antonio B, Minguillón J, Esquinas E, García-Escudero R, Errazquin R, Del Marro S, Pascual A, Lorz C, Juarranz Á, Barahona A, Balmaña J, Maher J, Bueren JA, Casado JA.

    Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.

    Molecular Therapy Oncology . 33(4): 201060-201060.

    [doi:10.1016/j.omton.2025.201060]

  • Abbad-Jaime de Aragon C, Berna-Rico E, Prieto L, Abarquero-Cerezo M, Gonzalez-Cantero Á.

    Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis.

    JOURNAL OF DERMATOLOGICAL TREATMENT . 36(1): 2486702-2486702.

    [doi:10.1080/09546634.2025.2486702]

  • Abbad-Jaime De Aragón C, Berna-Rico E, Jaén P, Blauvelt A, González-Cantero Á.

    Bimekizumab as-needed dosing in patients with psoriasis: a case series.

    JOURNAL OF DERMATOLOGICAL TREATMENT . 36(1): 2492197-2492197.

    [doi:10.1080/09546634.2025.2492197]

  • Krajewski PK, Jastrzab B, Szepietowski JC, Jankowska-Konsur A, Saceda Corralo D.

    Immune-Mediated Disorders in Patients With Alopecia Areata: Systematic Review and Meta-Analysis.

    INTERNATIONAL JOURNAL OF DERMATOLOGY . 64(11): 2029-2037.

    [doi:10.1111/ijd.17895]

  • Jastrzab-Miskiewicz B, Szepietowski JC, Saceda Corralo D, Krajewski PK.

    Is Spontaneous Regrowth in Alopecia Areata Possible: A Systematic Review and Meta-analysis of Placebo-controlled Studies.

    ACTA DERMATO-VENEREOLOGICA . 105: .

    [doi:10.2340/actadv.v105.44153]

  • Rodriguez-Tamez G, Imbernon-Moya A, Saceda-Corralo D, Vano-Galvan S.

    [Translated article] Dermatology Update on the Challenging Trichodynia.

    ACTAS DERMO-SIFILIOGRAFICAS . 116(9): .

    [doi:10.1016/j.ad.2025.07.006]

  • Strober BE, Blauvelt A, van de Kerkhof PC, Gonzalez-Cantero A, El-Kalioby M, Gonzales C, Matlock BH, Rob F, Asawanonda P, Chandra R, Maul JT, Torres T, Skov L.

    International Psoriasis Council Psoriasis Disease Severity Reclassification: Update on Validity, Acceptance, and Implementation.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 93(4): 1154-1157.

    [doi:10.1016/j.jaad.2025.05.1445]

  • Lecumberri A, Berna-Rico E, Gelfand JM, Svedbom A, Abbad-Jaime de Aragón C, Neria F, Monge D, Ballester-Martínez A, Pindado-Ortega C, Castellanos-González M, Llamas-Velasco M, Barderas MG, Solís J, Fernández-Friera L, Jaén P, Stahle M, Mehta NN, González-Cantero Á.

    Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY . 145(10): .

    [doi:10.1016/j.jid.2025.03.014]

  • Gold LS, Armstrong AW, Bissonnette R, Magnolo N, Vender RB, Sebastian M, Galimberti ML, Tsianakas A, Arnone M, Wallace P, Simon M, Riera-Monroig J, Gerdes S, Waibel J, Gonzalez-Cantero A, Schwarz B, Tada Y, Cecchini M, Ehst B, Kircik L, Kephart L, Reyes-Servin O, Edem BE, Campbell JH, Shen YK, Cresswell K, Li S, DeKlotz CMC, Nunes F, Papp KA.

    Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.

    Lancet (London, England) . 406(10510): 1363-1374.

    [doi:10.1016/S0140-6736(25)01576-4]

  • Hanson KA, Austin J, Clayton N, Anderson P, Vano-Galvan S, Marwaha S, Kurosky SK, Lejeune A, Piercy J, Law EH.

    Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles.

    ADVANCES IN THERAPY . 42(9): 4556-4570.

    [doi:10.1007/s12325-025-03302-8]

  • de Nicolas-Ruanes B, Fernandez-Lozano C, Gutierrez-Canales P, Ballester-Martinez A, Rodriguez-Otero N, Martinez-Botas J, De La Hoz Caballer B, Andres-Martin A, Solano-Solares E, Gomez-Salazar Lopez-Silanes ME, Diaz-Montalvo LG, Arrebola DM, Stewart-Delcid VL, Garcia-Mouronte E, Azcarraga-Llobet C, Berna-Rico E, Ortega-Sanchez S, Fernandez-Guarino M.

    Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development.

    INTERNATIONAL JOURNAL OF DERMATOLOGY . 64(9): 1636-1643.

    [doi:10.1111/ijd.17849]

  • Jimenez-Cauhe J, González-Ramos M, Imbernon-Moya A, Balaguera-Orjuela V, Hermosa-Gelbard A, Pindado-Ortega C, Buendia-Castaño D, Gil-Redondo R, Saceda-Corralo D, Vaño-Galvan S.

    Safety and tolerability of low-dose oral minoxidil in patients aged 65 or older: A multicenter study of 321 patients.

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 93(3): 767-769.

    [doi:10.1016/j.jaad.2025.05.1363]

  • Alonso-Mtz de Salinas L, Garcia-Mouronte E, Naharro-Rodriguez J, Perez-Gonzalez LA, Fernández-Guarino M.

    Optimization of Photodynamic Therapy in Dermatology: The Role of Light Fractionation.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(16): .

    [doi:10.3390/ijms26168054]

  • Alonso-Mtz de Salinas L, Naharro-Rodriguez J, Dominguez-Lopez R, Santos-Latasa B, Lecumberri-Indart A, Fernandez-Guarino M, Perez-Garcia B.

    Cinacalcet-Induced Hypocalcemia in Refractory Darier Disease.

    BRITISH JOURNAL OF DERMATOLOGY . 193(3): 560-561.

    [doi:10.1093/bjd/ljaf176]

  • Gómez de Las Heras MM, Carrasco E, Pérez-Manrique M, Inohara N, Delgado-Pulido S, Fernández-Almeida Á, Gálvez-Castaño MI, Francos-Quijorna I, Simó C, García-Cañas V, Escrig-Larena JI, Aranda JF, Soto-Heredero G, Gabandé-Rodríguez E, Blanco EM, Días-Almeida J, Núñez G, Mittelbrunn M.

    CD4 T cell therapy counteracts inflammaging and senescence by preserving gut barrier integrity.

    Science immunology . 10(110): .

    [doi:10.1126/sciimmunol.adv0985]

  • Moreno-Arrones OM, Hermosa-Gelbard A, Saceda-Corralo D, Jimenez-Cauhe J, Ortega-Quijano D, Pirmez R, Vañó-Galván S.

    Minoxidil oral a dosis altas para el tratamiento de la alopecia androgenética.

    ACTAS DERMO-SIFILIOGRAFICAS . 116(7): .

    [doi:10.1016/j.ad.2025.05.018]

  • Ortiz-Lazo E, Velasco-Tamariz V, Saceda-Corraló D, Wortsman X.

    [[Translated article]]Imaging modalities in trichology: Ultrasound, reflectance confocal microscopy, and optical coherence tomography.

    ACTAS DERMO-SIFILIOGRAFICAS . 116(7): .

    [doi:10.1016/j.ad.2025.05.009]

  • Saceda-Corralo D, Vañó-Galván S.

    Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority.

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 39(6): 1072-1073.

    [doi:10.1111/jdv.20691]